The Latin America, Middle East and Africa Gabapentin Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).
The market's growth is further fueled by awareness efforts like National Epilepsy Awareness Month in November, which work to increase understanding of the condition and encourage proactive measures to help control it. Also, more doctors nowadays are prescribing gabapentin rather than opioids to significantly reduce drug addiction. As a result, this is expected to increase the demand for medicine. The rising demand for gabapentin as a painkiller, particularly for neuropathic pain, is one of the main factors driving the market.
In addition, the increasing prevalence of chronic pain diseases like spinal cord injuries, shingles, and diabetic neuropathy, which are challenging to treat with traditional medicines, also increases the demand for gabapentin drugs. Therefore, many doctors are now prescribing gabapentin "off-label" for both chronic and acute pain, even though the medication was initially created and used to treat epilepsy and seizures. Many doctors recommend it in place of opioids, and some recommend it in addition to opioids.
Premised on the Global Burden of Disease (GBD) Study results, it has been shown that non-communicable diseases (NCD) are emerging as the primary factor in causing death and disability in the Arab region. Years of life lost to early mortality and years spent with a disability are measured using disability-adjusted life years (DALYs), a useful tool for quantifying and ranking disease burden. Neurological illnesses constitute up to 3% of worldwide DALYs, and one-fourth of this category comprises epilepsy. Additionally, among the various causes of DALY, epilepsy was ranked at the 31st position in the region of North Africa and the Middle East. Therefore, the rising incidences of epilepsy and chronic pain in the region are the main factors accelerating the expansion of the gabapentin market in the region.
The Brazil market dominated the LAMEA Gabapentin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $44.2 million by 2028. The Argentina market is experiencing a CAGR of 8.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.3% during (2022 - 2028).
Based on Application, the market is segmented into Epilepsy, Restless Legs Syndrome, Neuropathic Pain, and Others. Based on Dosage Form, the market is segmented into Capsule, Tablet and Oral Solution. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Gabapentin Market is Projected to reach USD 2.6 Billion by 2028, at a CAGR of 4.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Aurobindo Pharma Limited, Amneal Pharmaceuticals, Inc., Cipla Limited, and Apotex, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Epilepsy
- Restless Legs Syndrome
- Neuropathic Pain
- Others
By Dosage Form
- Capsule
- Tablet
- Oral Solution
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Zydus Lifesciences Ltd.
- Glenmark Pharmaceuticals Limited
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Aurobindo Pharma Limited
- Amneal Pharmaceuticals, Inc.
- Cipla Limited
- Apotex, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Gabapentin Market, by Application
1.4.2 LAMEA Gabapentin Market, by Dosage Form
1.4.3 LAMEA Gabapentin Market, by Distribution Channel
1.4.4 LAMEA Gabapentin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Gabapentin Market by Application
3.1 LAMEA Epilepsy Market by Country
3.2 LAMEA Restless Legs Syndrome Market by Country
3.3 LAMEA Neuropathic Pain Market by Country
3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Gabapentin Market by Dosage Form
4.1 LAMEA Capsule Market by Country
4.2 LAMEA Tablet Market by Country
4.3 LAMEA Oral Solution Market by Country
Chapter 5. LAMEA Gabapentin Market by Distribution Channel
5.1 LAMEA Hospital Pharmacy Market by Country
5.2 LAMEA Retail Pharmacy Market by Country
5.3 LAMEA Online Pharmacy Market by Country
Chapter 6. LAMEA Gabapentin Market by Country
6.1 Brazil Gabapentin Market
6.1.1 Brazil Gabapentin Market by Application
6.1.2 Brazil Gabapentin Market by Dosage Form
6.1.3 Brazil Gabapentin Market by Distribution Channel
6.2 Argentina Gabapentin Market
6.2.1 Argentina Gabapentin Market by Application
6.2.2 Argentina Gabapentin Market by Dosage Form
6.2.3 Argentina Gabapentin Market by Distribution Channel
6.3 UAE Gabapentin Market
6.3.1 UAE Gabapentin Market by Application
6.3.2 UAE Gabapentin Market by Dosage Form
6.3.3 UAE Gabapentin Market by Distribution Channel
6.4 Saudi Arabia Gabapentin Market
6.4.1 Saudi Arabia Gabapentin Market by Application
6.4.2 Saudi Arabia Gabapentin Market by Dosage Form
6.4.3 Saudi Arabia Gabapentin Market by Distribution Channel
6.5 South Africa Gabapentin Market
6.5.1 South Africa Gabapentin Market by Application
6.5.2 South Africa Gabapentin Market by Dosage Form
6.5.3 South Africa Gabapentin Market by Distribution Channel
6.6 Nigeria Gabapentin Market
6.6.1 Nigeria Gabapentin Market by Application
6.6.2 Nigeria Gabapentin Market by Dosage Form
6.6.3 Nigeria Gabapentin Market by Distribution Channel
6.7 Rest of LAMEA Gabapentin Market
6.7.1 Rest of LAMEA Gabapentin Market by Application
6.7.2 Rest of LAMEA Gabapentin Market by Dosage Form
6.7.3 Rest of LAMEA Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
TABLE 1 LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 4 LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 5 LAMEA Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 14 LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 15 LAMEA Capsule Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Capsule Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Tablet Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Tablet Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 31 Brazil Gabapentin Market, 2018 - 2021, USD Million
TABLE 32 Brazil Gabapentin Market, 2022 - 2028, USD Million
TABLE 33 Brazil Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 34 Brazil Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 35 Brazil Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 36 Brazil Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 37 Brazil Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 38 Brazil Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 39 Argentina Gabapentin Market, 2018 - 2021, USD Million
TABLE 40 Argentina Gabapentin Market, 2022 - 2028, USD Million
TABLE 41 Argentina Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 42 Argentina Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 43 Argentina Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 44 Argentina Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 45 Argentina Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 46 Argentina Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 47 UAE Gabapentin Market, 2018 - 2021, USD Million
TABLE 48 UAE Gabapentin Market, 2022 - 2028, USD Million
TABLE 49 UAE Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 50 UAE Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 51 UAE Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 52 UAE Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 53 UAE Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 54 UAE Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Gabapentin Market, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Gabapentin Market, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 63 South Africa Gabapentin Market, 2018 - 2021, USD Million
TABLE 64 South Africa Gabapentin Market, 2022 - 2028, USD Million
TABLE 65 South Africa Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 66 South Africa Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 67 South Africa Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 68 South Africa Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 69 South Africa Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 70 South Africa Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 71 Nigeria Gabapentin Market, 2018 - 2021, USD Million
TABLE 72 Nigeria Gabapentin Market, 2022 - 2028, USD Million
TABLE 73 Nigeria Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 74 Nigeria Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 75 Nigeria Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 76 Nigeria Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 77 Nigeria Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 Nigeria Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 87 Key Information – Zydus Lifesciences Ltd.
TABLE 88 Key Information – Glenmark Pharmaceuticals Limited
TABLE 89 Key Information – Pfizer, Inc.
TABLE 90 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 91 Key Information – Alkem Laboratories Ltd.
TABLE 92 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 93 key information – Aurobindo Pharma Limited
TABLE 94 Key Information – Amneal Pharmaceuticals, INc.
TABLE 95 Key Information – Cipla Limited
TABLE 96 Key Information – Apotex, Inc.
List of Figures
FIG 1 Methodology for the research